Document is current
Any future updates will be listed below
-
Authors
Bailey, Clare https://orcid.org/0000-0003-2141-4512
Chandran, Manju
Gale, Richard
Narendran, Nirodhini
Talks, James
McGoey, Hellen https://orcid.org/0000-0002-9579-9390
Keshk, Zinab
Morgan-Warren, Peter
Allmeier, Helmut
Machewitz, Tobias
Patel, Praveen J. https://orcid.org/0000-0001-8682-4067
Varma, Deepali
-
Funding
Funding for this research was provided by:
Bayer AG, Germany
- License Information
-
More Information
Article History
Received: 10 May 2024
Revised: 28 November 2024
Accepted: 12 December 2024
First Online: 24 December 2024
Competing interests
: CB: Travel support/lecture fees from Alimera Sciences, Apellis, Bayer, Novartis, and Roche; and attendance at advisory board meetings for Apellis, Bayer, Boehringer Ingelheim, Janssen, Novartis, and Roche. MC: Nothing to disclose. RG: Consultant/advisory boards: Allergan, Alimera, Bayer, Novartis, and Santen; Educational travel grants: Allergan, Bayer, Heidelberg, and Novartis; Research grants: Allergan, Bayer, Novartis, and Roche. NN: Nothing to disclose. JT: Advisory board member, speaker fees, and research support: Bayer and Novartis; Research grants: Boehringer Ingelheim and Roche; Consultant: Bayer. HM: Employee of Bayer Plc, UK. ZK: Employee of Bayer Plc, UK. PMW: Employee of Bayer Consumer Care AG, Basel, Switzerland. HA: Employee of Bayer Consumer Care AG, Basel, Switzerland. TM: Employee of Bayer AG, Berlin, Germany. PJP: Honoraria/attendance at advisory boards for Bayer, Boehringer Ingelheim and Roche, Speaker fees from Bayer and Roche. Educational travel grants from Roche and Bayer. DV: Speaker fees, AbbVie, Bayer, Novartis and Roche; Honoraria/attendance at advisory boards for Bayer, AbbVie, Novartis, Roche and Teva Pharmaceuticals; Educational travel grants from AbbVie, Roche and Bayer; Principal investigator in clinical trials for AbbVie, Bayer, Novartis and Roche.
